Document is current
Any future updates will be listed below
-
Authors
Gopal, Srihari
Lane, Rosanne
Nuamah, Isaac
Copenhaver, Margaret
Singh, Jaskaran
Hough, David
Bach, Mark
Savitz, Adam
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00488319 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study
https://doi.org/10.1007/s40263-017-0437-9
-
Funding
Funding for this research was provided by:
Janssen Research and Development
- License Information
-
More Information
Article History
First Online: 28 June 2017
Compliance with Ethical Standards
:
: The study and writing/editorial support for this paper was funded by Janssen Research & Development, LLC, NJ, USA.
: MC is a contract employee of Janssen Research & Development, LLC, NJ, USA. SG, RL, IN, JS, DH, MB, and AS are employees of Janssen Research & Development, LLC, or of Janssen Pharmaceutical KK, and hold stock in the company.
: The Independent Ethics Committee or Institutional Review Board at each study site approved the protocol, and the study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, consistent with Good Clinical Practices, and applicable regulatory requirements. All patients provided assent, and parents or guardians of these adolescent patients provided written informed consent before entering the study.
